Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Krueger

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Archives of Otolaryngology--Head & Neck Surgery|December 1, 1988
Pathologic quiz case 2. Benign capillary hemangiomaR A Krueger, D Porto
The Journal of Infectious Diseases|November 1, 1984
The biochemistry of opsonization: central role of the reactive thiolester of the third component of complementM K Hostetter, R A Krueger, D J Schmeling
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 19, 2010
Some pharmacological characteristics of bacitracin; absorption and excretion of bacitracin in the dogJ V SCUDI, M E CLIFT, R A KRUEGER
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
Amidation of C3 at the thiolester site: stimulation of chemiluminescence and phagocytosis by a new inflammatory mediatorD L Gordon, R A Krueger, P G Quie, et al.
Journal of Medical Ethics|March 3, 2009
Subjects' views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) studyN Sofaer, C Thiessen, S D Goold, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Archives of Otolaryngology--Head & Neck Surgery|December 1, 1988
Pathologic quiz case 2. Benign capillary hemangiomaR A Krueger, D Porto
The Journal of Infectious Diseases|November 1, 1984
The biochemistry of opsonization: central role of the reactive thiolester of the third component of complementM K Hostetter, R A Krueger, D J Schmeling
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 19, 2010
Some pharmacological characteristics of bacitracin; absorption and excretion of bacitracin in the dogJ V SCUDI, M E CLIFT, R A KRUEGER
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
Amidation of C3 at the thiolester site: stimulation of chemiluminescence and phagocytosis by a new inflammatory mediatorD L Gordon, R A Krueger, P G Quie, et al.
Journal of Medical Ethics|March 3, 2009
Subjects' views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) studyN Sofaer, C Thiessen, S D Goold, et al.
Pageof 1